PROM1 and neoplasm: demonstrated the unparalleled tumor-initiating capacity of CD133+ CSCs: xenotransplantation of as few as 1,000 CD133+ cells sufficed for tumor engraftment in immunocompromised murine models, whereas 1 × 106 CD133− counterparts failed to propagate neoplasia (27).